Participation in phase 1 trials for patients with cancer
The Lancet, Sept. 2022
Antoine Italiano
https://www.sciencedirect.com/science/article/abs/pii/S0140673622015331
DOI: 10.1016/S0140-6736(22)01533-1
No abstract available
The Lancet, Sept. 2022
Antoine Italiano
https://www.sciencedirect.com/science/article/abs/pii/S0140673622015331
DOI: 10.1016/S0140-6736(22)01533-1